[HSF] Trip to Croatia
bbiocina at kbd.hr
bbiocina at kbd.hr
Sat Apr 7 22:36:07 EDT 2007
As discussion is again approaching Mitrofast concept , I have no choice
than to ( unvillingly) again declare that:
1. Rather than a device , Mitrofast is a concept of arteficial
coaptation surface of the posterior leaflet ( hemi-valve replacement).
Arteficial support of other two main parts of the mitral valve( ring
and suspensory apparatus) had already been successfuly exploited(ring
much earlier , chordae later on)
2. Feasibility study conducted here in Zagreb proved that the concept
works ( ECHOs available) , at least for short/mid term ( longest
follow up 2 1/2 y). However , actual design of device(s) based on such
concept is amenable to changes/evolution.
3.Skepticism about that concept is mainly based on presumption that
natural coaptation surface is better than arteficial (scaffolded treated
xenopericardium). If it was true , natural suspensory apparatus ( with
accordingly based techniques of chordal shortening , transposition
etc.) should be better of arteficial chordal (Goretex) support , and
that is not the case. Moreover , all of us witnessed famous
surgeons/experts ( names ommited) who claimed superiority of natural
suspensory apparatus for decades. As there is no proof that arteficial
coaptation surface is better than natural one either , I think time
and reported experience will be the best judge.
4. Even if I agreed that conventional reparability of the posterior
leaflet makes Mitrofast unnecessary , "repairability" contains a broad
spectrum of difficulty- from simple quadrangular/imbrication to very
complex time consuming repairs). As Mitrofast implantation technique
is completely unrelated to the extent of PML pathlogy , the question of
cost ( e.g. x-clamp time) of PML repairability may also be asked.
5. In case of completely unrepairable PML , Mitrofast concept is an
viable option. Surgeons from Augsburg , Germany , were able to repair
two PML endocarditis ( one healed , one active) with excision of PML
and Mitrofast placement. It shows there is , at least , a niche for
such concept.( I hope they will not wait for publication as long as I
do).
6. As , even in Croatia , we see wery few reumatic patients , the
judgement of applicability should be left to Prasanna and his fellows
, as they see such pathology on daily basis.
Bojan
On 4/7/2007, "Hgrmd at aol.com" <Hgrmd at aol.com> wrote:
>Bob,
> While he was still in Croatia, Prasanna and I were talking off line about
>Mitrofast. He was discussing possible practical uses of Mitrofast, and I'd
>like to share them with HSF since I think they could turn out to be apt. I'm
>in complete agreement that Mitrofast doesn't make much sense if the posterior
>leaflet is repairable. Carpentier's techniques and Goretex should be able
>to reliably repair such leaflets. However, with severe rheumatic damage or
>perhaps a calcified posterior annulus, perhaps Mitrofast might be usable and
>better (?) than a replacement.
>
>Hal
>
>
>
>************************************** See what's free at http://www.aol.com.
>_______________________________________________
>OpenHeart-L mailing list
>
>Send postings to:
> OpenHeart-L at lists.hsforum.com
>
>To UNSUBSCRIBE, to CHANGE email address, or to view archives:
>http://mmp.cjp.com/mailman/listinfo/openheart-l
>
>All messages transmitted by the OpenHeart-L are subject to the policies and
>disclaimers posted at:
>http://www.hsforum.com/listdisclaim
>-----------------------------------------
More information about the OpenHeart-L
mailing list